ANDUELO

Glaxo Group Limited

Application Filed: 2019-05-16

Trademark Application Details

Status

402

Dead/Abandoned

IR CANCELLED; US APPLICATION ABANDONED

Research	OneLook Acronym Finder
Serial Number	79261542
Mark Drawing Code	4000: Illustration: Drawing with word(s)/letter(s)/number(s) in Block form
Cancellation Code	H
Law Office Assigned	N10
Employee Name	ZAK, HENRY S

Timeline

2019-05-16	Application Filed
2019-07-25	Abandon
2019-07-25	Status: Dead/Abandoned
2019-08-08	Location: PUBLICATION AND ISSUE SECTION
2019-08-12	Transaction Date

Trademark Applicants & Owners

Owner:	Glaxo Group Limited
Entity Statement	Registered Company
Address	980 Great West Road Brentford, Middlesex TW8 9GS GB GB8
Legal Entity Type
Legal Entity State	GB8

Documents

Click the blue "Refresh" button to load certificates, specimines, application, and other documents.

Attorney of Record

Legal Brand Protection,
GlaxoSmithKline
980 Great West Road
Brentford, Middlesex TW8 9GS
UNITED KINGDOM

Good, Services, and Codes

International Codes:	5
U.S. Codes:	006,018,044,046,051,052

Type Code	Type
GS0051	Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Type Code

Type

GS0051

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; vaccines

Trademark Filing History

Description	Date	Event Coding
SN ASSIGNED FOR SECT 66A APPL FROM IB	2019-06-27	1 REPR M:
LIMITATION FROM ORIGINAL APPLICATION ENTERED	2019-07-10	2 LIMI I:Incoming Correspondence
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM	2019-07-18	3 NWOS I:Incoming Correspondence
APPLICATION FILING RECEIPT MAILED	2019-07-23	4 MAFR O:Outgoing Correspondence
ASSIGNED TO EXAMINER	2019-08-01	5 DOCK D:Assigned to Examiner
APPROVED FOR PUB - PRINCIPAL REGISTER	2019-08-06	6 CNSA O:Outgoing Correspondence
DEATH OF INTERNATIONAL REGISTRATION	2019-08-09	7 DETH P:
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED	2019-08-10	8 DENA O:Outgoing Correspondence

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.